Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P LeHoang

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Medicine|July 27, 2001
Chronic severe uveitis: etiology and visual outcome in 927 patients from a single centerB Bodaghi, N Cassoux, B Wechsler, et al.
Ophthalmology|June 1, 1989
Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndromeP Lehoang, B Girard, M Robinet, et al.
Ophthalmology|September 1, 1991
Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndromeI Cochereau-Massin, P Lehoang, M Lautier-Frau, et al.
American Journal of Ophthalmology|August 15, 1992
Ocular toxoplasmosis in human immunodeficiency virus-infected patientsI Cochereau-Massin, P LeHoang, M Lautier-Frau, et al.
Clinical and Experimental Rheumatology|November 2, 2004
Infliximab in refractory uveitis due to Behçet's diseaseB Wechsler, R Sablé-Fourtassou, B Bodaghi, et al.
Journal Francais D'Ophtalmologie|March 16, 2005
[Diagnostic and therapeutic management of Vogt-Koyanagi-Harada syndrome]V Touitou, C Escande, B Bodaghi, et al.
Leukemia & Lymphoma|October 1, 1996
A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 casesC Soussain, H Merle-Béral, I Reux, et al.
Medicine|February 18, 1998
Susac syndromeT Papo, V Biousse, P Lehoang, et al.
Ocular Immunology and Inflammation|March 23, 2001
Ocular and central nervous system lymphoma: clinical features and diagnosisN Cassoux, H Merle-Beral, V Leblond, et al.
Annals of the Rheumatic Diseases|May 18, 2005
Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factorsB Bodaghi, E Bui Quoc, B Wechsler, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Medicine|July 27, 2001
Chronic severe uveitis: etiology and visual outcome in 927 patients from a single centerB Bodaghi, N Cassoux, B Wechsler, et al.
Ophthalmology|June 1, 1989
Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndromeP Lehoang, B Girard, M Robinet, et al.
Ophthalmology|September 1, 1991
Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndromeI Cochereau-Massin, P Lehoang, M Lautier-Frau, et al.
American Journal of Ophthalmology|August 15, 1992
Ocular toxoplasmosis in human immunodeficiency virus-infected patientsI Cochereau-Massin, P LeHoang, M Lautier-Frau, et al.
Clinical and Experimental Rheumatology|November 2, 2004
Infliximab in refractory uveitis due to Behçet's diseaseB Wechsler, R Sablé-Fourtassou, B Bodaghi, et al.
Journal Francais D'Ophtalmologie|March 16, 2005
[Diagnostic and therapeutic management of Vogt-Koyanagi-Harada syndrome]V Touitou, C Escande, B Bodaghi, et al.
Leukemia & Lymphoma|October 1, 1996
A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 casesC Soussain, H Merle-Béral, I Reux, et al.
Medicine|February 18, 1998
Susac syndromeT Papo, V Biousse, P Lehoang, et al.
Ocular Immunology and Inflammation|March 23, 2001
Ocular and central nervous system lymphoma: clinical features and diagnosisN Cassoux, H Merle-Beral, V Leblond, et al.
Annals of the Rheumatic Diseases|May 18, 2005
Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factorsB Bodaghi, E Bui Quoc, B Wechsler, et al.
Pageof 11